Vrouyr Bilemjian: We have developed a tumor targeting drug delivery systems

Vrouyr Bilemjian, Solutions and Strategy Consultant at Innoplexus, made the following post on LinkedIn:

“Excited to share my latest publication: ‘Direct Functionalization of Polysaccharide-Based Xylan Phenyl Carbonate Nanoparticles with Tumor Cell Specific Antibodies‘.

Here in this research paper, we have developed a tumor targeting drug delivery systems, achieved by immobilizing Cetuximab and Atezolizumab on polysaccharide-based nanoparticles.

Grateful for the amazing team effort behind this research. Thank you all!”

Source: Vrouyr Bilemjian/LinkedIn